Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

386 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-07-01

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective analysis of pre and post-Enhanced Recovery after Surgery for Total mastectomy pathway implementation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients

NCT03541161

Breast Cancer

COMPLETED

RCT Implant Based Breast Reconstruction

NCT04558138

Mastectomy

COMPLETED NA

What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery

NCT05823467

Breast Cancer

RECRUITING NA

Inertial Rehabilitation in Women After Mastectomy

NCT04621942

Breast Cancer Mastectomy; Lymphedema

COMPLETED NA

Quantification of Breast Sensation Following Postmastectomy Breast Reconstruction

NCT00588419

Breast Cancer Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Retrospective analysis of pre- and post-Enhanced Recovery after surgery for total mastectomy pathway implementation in patients at Mount Zion Hospital. We examined perioperative opioid consumption, pain scores, post-operative nausea and vomiting, benzodiazepine use, length of stay for the time period before and after implementation of an Enhanced Recovery after Surgery pathway for Total mastectomy. Pathway features included preoperative acetaminophen and gabapentin, minimizing opioids, postoperative NSAIDs, Pecs blocks, and aggressive postoperative nausea and vomiting prophylaxis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mastectomy Breast Cancer Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pre-ERAS

Patients cared for prior to the implementation of the Enhanced Recovery after surgery for total mastectomy pathway

No interventions assigned to this group

post-ERAS

patients cared for after the implementation of the Enhanced Recovery after surgery for total mastectomy pathway. Pathway included preoperative acetaminophen and gabapentin, Pec blocks, multimodal analgesia postoperatively and aggressive PONV treatment.